- Patent Title: Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
-
Application No.: US15921306Application Date: 2018-03-14
-
Publication No.: US10561654B2Publication Date: 2020-02-18
- Inventor: Daya Verma , Yogita Krishnamachari , Xiaohong Shen , Hanchen Lee , Ping Li , Rajinder Singh , LayChoo Tan
- Applicant: Array BioPharma Inc.
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K9/20 ; A61K9/48 ; A61K9/00 ; A61K9/28
Abstract:
This invention relates to solid oral pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (COMPOUND A) and the use of these formulations for treating proliferative diseases, such as solid tumor diseases.
Public/Granted literature
- US20190054086A1 PHARMACEUTICAL FORMULATIONS Public/Granted day:2019-02-21
Information query
IPC分类:
